Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Recent advances in neuroblastoma.

Maris JM.

N Engl J Med. 2010 Jun 10;362(23):2202-11. doi: 10.1056/NEJMra0804577. Review. No abstract available.

2.

Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: results of German trials.

Simon T, Berthold F, Borkhardt A, Kremens B, De Carolis B, Hero B.

Pediatr Blood Cancer. 2011 Apr;56(4):578-83. doi: 10.1002/pbc.22693. Epub 2010 Dec 9.

PMID:
21298742
3.

High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.

Yalçin B, Kremer LC, van Dalen EC.

Cochrane Database Syst Rev. 2015 Oct 5;(10):CD006301. doi: 10.1002/14651858.CD006301.pub4. Review.

PMID:
26436598
4.

[Efficacy of chemotherapy regimen using ifosphamide and carboplatin on recurrent or refractory neuroblastoma].

Zhen ZJ, Sun XF, Xia Y, Wang ZH, Ling JY.

Ai Zheng. 2006 Dec;25(12):1550-2. Chinese.

PMID:
17166384
5.

High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.

Yalçin B, Kremer LC, Caron HN, van Dalen EC.

Cochrane Database Syst Rev. 2013 Aug 22;(8):CD006301. doi: 10.1002/14651858.CD006301.pub3. Review. Update in: Cochrane Database Syst Rev. 2015;(10):CD006301.

PMID:
23970444
6.

Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification.

Kaneko M, Tsuchida Y, Mugishima H, Ohnuma N, Yamamoto K, Kawa K, Iwafuchi M, Sawada T, Suita S.

J Pediatr Hematol Oncol. 2002 Nov;24(8):613-21.

PMID:
12439032
7.

The role of BMT for neuroblastoma relapse patients. A report of the EBMT-STR.

Ladenstein R, Chauvin F, Garaventa A, Bernard JL, Zucker JM, Lutz P, Bordigoni P, Plouvier E, Cahn JY, Frappaz D, et al.

Bone Marrow Transplant. 1991;7 Suppl 2:90. No abstract available.

PMID:
1878738
8.

Hodgkin's disease: treatment of relapsed disease.

Cavalli FG.

Ann Oncol. 2002;13 Suppl 4:159-62. Review. No abstract available.

PMID:
12401683
9.

High-dose consolidation chemotherapy in infants with stage 4 neuroblastoma. The European Group for Bone Marrow Transplantation.

Ladenstein R, Lasset C, Hartmann O, Garaventa A, Philip T.

Eur J Cancer. 1993;29A(11):1632. No abstract available.

PMID:
8217371
10.

PCV salvage chemotherapy for recurrent primary CNS lymphoma.

Herrlinger U, Brugger W, Bamberg M, Küker W, Dichgans J, Weller M.

Neurology. 2000 Apr 25;54(8):1707-8. No abstract available.

PMID:
10762527
11.

Did salvage ICE chemotherapy improve the outcome in primary resistant/relapsing stage III/IV neuroblastoma?

Abdel Rahman H, Moussa EA, Zekri WZ, El Debawy E, Mostafa NE, Yones A, Ezzat S, Rayan Ael R.

J Egypt Natl Canc Inst. 2011 Mar;23(1):47-53. doi: 10.1016/j.jnci.2011.07.007. Epub 2011 Sep 8.

12.

Salvaging AML with CLAG: novel option, or more of the same?

Wei A, Teh TC.

Leuk Res. 2011 Mar;35(3):297-8. doi: 10.1016/j.leukres.2010.10.015. Epub 2010 Nov 11. No abstract available.

PMID:
21074270
13.

Disease control intervals in high-risk neuroblastoma.

Santana VM, Furman WL, McGregor LM, Billups CA.

Cancer. 2008 Jun 15;112(12):2796-801. doi: 10.1002/cncr.23507.

14.

Gefitinib in combination with oral topotecan and cyclophosphamide in relapsed neuroblastoma: pharmacological rationale and clinical response.

Donfrancesco A, De Ioris MA, McDowell HP, De Pasquale MD, Ilari I, Jenkner A, Castellano A, Cialfi S, De Laurentis C, Dominici C.

Pediatr Blood Cancer. 2010 Jan;54(1):55-61. doi: 10.1002/pbc.22219.

PMID:
19821523
15.
16.

High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.

Yalçin B, Kremer LC, Caron HN, van Dalen EC.

Cochrane Database Syst Rev. 2010 May 12;(5):CD006301. doi: 10.1002/14651858.CD006301.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;8:CD006301.

PMID:
20464740
17.

Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: results of the German Neuroblastoma Trial.

Klingebiel T, Berthold F, Treuner J, Schwabe D, Fischer M, Feine U, Maul FD, Waters W, Wehinger H, Niethammer D.

Med Pediatr Oncol. 1991;19(2):84-8.

PMID:
2011100
19.

New paclitaxel-cisplatin based chemotherapy regimen for advanced stage, recurrent, or refractory neuroblastoma-preliminary report.

Surico G, Muggeo P, De Leonardis F, Rigillo N.

Med Pediatr Oncol. 2003 Feb;40(2):130-2. No abstract available.

PMID:
12461803
20.

Impact of radiotherapy for high-risk neuroblastoma: a Children's Cancer Group study.

Haas-Kogan DA, Swift PS, Selch M, Haase GM, Seeger RC, Gerbing RB, Stram DO, Matthay KK.

Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):28-39.

PMID:
12694821

Supplemental Content

Support Center